Search Results - "Berro, Marlene"

Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemic by Gravelin, Misty, Wright, Jeanne, Holbein, M E Blair, Berro, Marlene, Brown, Jennifer S, Mashour, George A, Weatherwax, Kevin J

“…With no approved treatments for COVID-19 initially available, the Food and Drug Administration utilized multiple preapproval pathways to provide access to…”
Get full text

Relief of post-herpetic neuralgia by surgical removal of painful skin by Petersen, Karin L, Rice, Frank L, Suess, Fred, Berro, Marlene, Rowbotham, Michael C

“…We present a case of longstanding PHN treated by skin excision of the area of greatest pain (11.3×26.0 cm 2). The operation reduced pain, eliminated tactile…”
Get full text

Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Patients Who Received Compassionate-Use Leronlimab by Yang, Bryant, Fulcher, Jennifer A, Ahn, Jenny, Berro, Marlene, Goodman-Meza, David, Dhody, Kush, Sacha, Jonah B, Naeim, Arash, Yang, Otto O

“…Abstract Background Leronlimab, a monoclonal antibody blocker of C-C chemokine receptor type 5 originally developed to treat human immunodeficiency virus…”
Get full text

Natural history of pain following herpes zoster by Thyregod, Hans Gustav, Rowbotham, Michael C., Peters, Michelle, Possehn, Jessica, Berro, Marlene, Petersen, Karin Lottrup

“…In a longitudinal observational study of 94 patients (39M:55F, mean age 69) at elevated risk for developing post herpetic neuralgia (PHN), the natural history…”
Get full text

Support for investigator-initiated clinical research involving investigational drugs or devices: the Clinical and Translational Science Award experience by Berro, Marlene, Burnett, Bruce K, Fromell, Gregg J, Hartman, Karen A, Rubinstein, Eric P, Schuff, Kathryn G, Speicher, Lisa A

“…Investigator-initiated research involving investigational drugs and devices is key to improving health. However, this requires the investigator to serve as a…”
Get full text

A Roadmap for Academic Health Centers to Establish Good Laboratory Practice–Compliant Infrastructure by Adamo, Joan E., Bauer, Gerhard, Berro, Marlene, Burnett, Bruce K., Hartman, Karen A., Masiello, Lisa M., Moorman-White, Diane, Rubinstein, Eric P., Schuff, Kathryn G.

“…Prior to human clinical trials, nonclinical safety and toxicology studies are required to demonstrate that a new product appears safe for human testing; these…”
Get full text